Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 6, 2011, Pages 987-994

  Pychyska Pokorska, Magdalena ^a   Pgowska Klimek, Izabela ^a   Krajewski, Wojciech ^a   Moll, Jacek Jan ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

cardiac; child; factor VIIa; hemostasis; neonate; postoperative hemorrhage; surgery

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; ERYTHROCYTE CONCENTRATE; FEMALE; HEART SURGERY; HEMOSTASIS; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NORWOOD PROCEDURE; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOSIS; TREATMENT RESPONSE;

ADOLESCENT; AGING; ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FACTOR VIIA; FEMALE; HEART DEFECTS, CONGENITAL; HEMOSTATICS; HEPARIN ANTAGONISTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; OFF-LABEL USE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PROTAMINES; PROTHROMBIN TIME; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 82255162862     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.05.012     Document Type: Article

References (36)

1. T.S. Hall, G.R. Brevetti, and A.J. Skoultchi Re-exploration for hemorrhage following open heart surgery differentiation on the causes of bleeding and the impact on patient outcomes Ann Thorac Cardiovasc Surg 7 2001 352 357
2. G.D. Williams, S.L. Bratton, and C. Ramamoorthy Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery Anesth Analg 89 1999 57 64
3. J. Jaggers, and J.H. Lawson Coagulopathy and inflammation in neonatal heart surgery: Mechanisms and strategies Ann Thorac Surg 81 2006 S2360 S2366
4. C. Negrier, and C.R. Hay The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa Semin Thromb Hemost 26 2000 407 412
5. M.C. Poon, and R. d'Oiron Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group Blood Coagul Fibrinolysis 11 suppl 1 2000 S55 S68
6. M. Al Douri, T. Shafi, and D. Al Khudairi Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery Blood Coagul Fibrinolysis 11 suppl 1 2000 S121 S127
7. U. Martinowitz, G. Kenet, and E. Segal Recombinant activated factor VII for adjunctive hemorrhage control in trauma J Trauma 51 2001 431 438
8. P. Kaliciski, A. Kamiski, and T. Drewniak Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII Transplant Proc 31 1999 378 379
9. S. Segal, I.Y. Shemesh, and R. Blumenthal Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa) Arch Gynecol Obstet 268 2003 266 267
10. J.L. Vincent, R. Rossaint, and B. Riou Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleedingA European perspective Crit Care 10 2006 R120
11. H.S. Agarwal, J.E. Bennett, and K.B. Churchwell Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery Ann Thorac Surg 84 2007 161 168
12. K.M. Brady, R.B. Easley, and J.D. Tobias Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage Paediatr Anaesth 16 2006 1042 1046
13. Y. Razon, E. Erez, and B. Vidne Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease Paediatr Anaesth 15 2005 235 240
14. N.A. Guzzetta, S. Huch, and J.D. Fernandez Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass Paediatr Anaesth 19 2009 364 370
15. J.R. Egan, A. Lammi, and D.N. Schell Recombinant activated factor VII in paediatric cardiac surgery Intensive Care Med 30 2004 682 685
16. T.J. Karsies, K.K. Nicol, and M.E. Galantowicz Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: A single institution experience Ann Thorac Surg 89 2010 570 576
17. M. Pychyska-Pokorska, J.J. Moll, and W. Krajewski The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass Pediatr Crit Care Med 5 2004 246 250
18. J.D. Tobias, J.W. Berkenbosch, and P. Russo Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant Pediatr Crit Care Med 4 2003 49 51
19. J.D. Tobias, J.M. Simsic, and S. Weinstein Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients J Intensive Care Med 19 2004 270 273
20. L. Leibovitch, G. Kenet, and K. Mazor Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery Pediatr Crit Care Med 4 2003 444 446
21. B. Sørensen, H.S. Asvaldsdottir, and B.R. Gudmindsdottir The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery Thromb Res 124 2009 695 700
22. T. Lang, K. Johanning, and H. Metzler The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia Anesth Analg 108 2009 751 758
23. B.E. Miller, S.R. Tosone, and N.A. Guzzetta Fibrinogen in children undergoing cardiac surgery: Is it effective? Anesth Analg 99 2004 1341 1346
24. T. Pietrucha, T. Wojciechowski, and J. Greger Differentiated reactivity of whole blood neonatal platelets to various agonists Platelets 12 2001 99 107
25. M. Hoffman, D.M. Monroe 3rd, and H.R. Roberts Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII Blood Coagul Fibrinolysis 9 suppl 1 1998 S61 S65
26. E. Erhardtsen Pharmacokinetics of recombinant activated factor VII (rFVIIa) Semin Thromb Hemost 26 2000 385 391
27. M. Levi, J.H. Levy, and H.F. Andersen Safety of recombinant activated factor VII in randomized clinical trials N Engl J Med 363 2010 1791 1800
28. B. Alioglu, Z. Avci, and K. Tokel Thrombosis in children with cardiac pathology: Analysis of acquired and inherited risk factors Blood Coagul Fibrinolysis 19 2008 294 304
29. K.C. Odegard, F.X. McGowan, and D. Zurakowski Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure Ann Thorac Surg 73 2002 1770 1777
30. J.M. Cholette, J.S. Rubenstein, and G.M. Alfieris Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery Ann Thorac Surg 84 2007 1320 1325
31. G. Balling, M. Vogt, and H. Kaemmerer Intracardiac thrombus formation after the Fontan operation J Thorac Cardiovasc Surg 119 2000 745 752
32. L.J. Bowman, W.E. Uber, and M.R. Stround Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery Ann Thorac Surg 85 2008 1669 1677
33. R. Gill, M. Herbertson, and A. Vuylsteke Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery Circulation 120 2009 21 27
34. D.N. Rosenthal, A.H. Friedman, and C.S. Kleinman Thromboembolic complications after Fontan operations Circulation 92 1995 287 293
35. G.J. Despotis, M.S. Avidan, and C.W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 72 2001 S1821 S1831
36. D.A. Gabriel, M. Carr, and H.R. Roberts Monitoring coagulation and the clinical effects of recombinant factor VIIa Semin Hematol 41 2004 20 24